Plavix Settlement Outcome May Make Industry Overly Cautious, Legal Experts Say
This article was originally published in The Pink Sheet Daily
Executive Summary
Collapse of Bristol/Sanofi generic settlement with Apotex will likely impact future brand-generic negotiations, attorneys predict.
You may also be interested in...
FTC Enjoins Warner Chilcott From Providing “Anything Of Value” To ANDA Filers
Commission settles charges against the brand drug maker related to generic Ovcon 35.
FTC Enjoins Warner Chilcott From Providing “Anything Of Value” To ANDA Filers
Commission settles charges against the brand drug maker related to generic Ovcon 35.
Apotex Alleges Bristol/Sanofi Misled Regulators On Plavix Settlement
Bristol/Sanofi made oral commitments to Apotex that were not included in a written settlement, Apotex claims in court documents.